Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons - Oesterheld, J; Ferguson, W; Kraveka, J M (J Clin Oncol, 2024)